Studies open for recruitment

 

Current projects

View all projects

Currently Recruiting in Liver Disease Studies

Our Liver Studies are ongoing, but are currently closed to recruitment

Currently Recruiting in General Oncology Studies

Protocol: (MK1308-001) (PI: Dr Victoria Atkinson) Short Title: Melanoma Cohort only Protocol Title: A Phase 1 Open Label, Multi-Arm, Multicenter Study of MK-1308 in Combination With  Pembrolizumab for Subjects With Advanced Solid Tumors Lay Title: Safety, Pharmacokinetics (PK), and Efficacy of MK-1308...

Currently Recruiting in Liver Cancer Studies

PROTOCOL: MK3475-966 (PI: DR WARREN JOUBERT) Protocol Title: A Phase 3 Randomized, Double Blind Study of Pembrolizumab Plus Gemcitabine/Cisplatin versus Placebo Plus Gemcitabine/Cisplatin as First-Line Therapy in Participants with Advanced and/or Unresectable Biliary Tract Carcinoma Click here for...

Currently Recruiting in Lung Cancer Studies

1. PROTOCOL: CA209-73L (PI: DR KEN OBYRNE) Short Title: CheckMate 73L Protocol Title: A Phase 3, Randomized, Open Label Study to Compare Nivolumab Plus Concurrent Chemoradiotherapy (CCRT) Followed by Nivolumab Plus Ipilimumab or Nivolumab Plus CCRT Followed by Nivolumab vs CCRT Followed by Durvalumab...

Currently Recruiting in Melanoma Studies

  PROTOCOL: CA209-76K (PI: DR VICTORIA ATKINSON) Short Title: CheckMate 76K Protocol Title: A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy With Nivolumab Versus Placebo After Complete Resection of Stage IIB/C Melanoma Lay Title: Effectiveness Study of Nivolumab Compared...

Currently Recruiting in Prostate Cancer Studies

1. PROTOCOL: (MK3475-641) (PI: DR PRETORIA BILINSKI) SHORT TITLE: KEYNOTE 641 Protocol Title: A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Lay Title: Study...

Currently Recruiting in Respiratory Studies

1. PROTOCOL: Z7224L02 (PI: DR RACHEL THOMSON) SHORT TITLE: THE PROMIS II STUDY Protocol Title: A Double-blind, Placebo-controlled, Multi-centre, Clinical Trial to Investigate the Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in the Treatment of Subjects With Non-cystic...

Resources

View Resources